Mount Sinai researchers identify cells linked to ventricular chamber development

[[{"fid":"22342","view_mode":"default","type":"media","attributes":{"height":187,"width":244,"style":"float: right; margin-left: 12px; margin-right: 12px;","alt":"Cells - Cells","class":"media-element file-default"}}]]Researchers from Mount Sinai in New York found a population of cells that are linked to the development of heart ventricular chambers.

The study, published in Nature Communications, revealed in-depth information of the formation of heart chambers that could help researchers better understand the biology behind heart defects like congenital heart disease.

Researchers examined the role that Foxa2, a protein-coding gene, played in the development of the endoderm and ectoderm during embryogenesis. Investigators found a population of progenitor cells expressing Foxa2 during early development that formed cells in both the left and right ventricular chambers, but not the atria, showing that atrial-ventricular segregation happens before the morphological establishment of differentiated cardiac structures.

"In addition to informing our understanding of early heart development, we hope that these findings will also lead to new protocols for the generation of ventricular cardiomyocytes in cell culture that could potentially be used in therapeutic settings,” said Nicole Dubois, PhD, the lead author on the study and an assistant professor at the Icahn School of Medicine at Mount Sinai, in a statement.

Though researchers don’t understand much about Foxa2, the study provides a foundation for future work that can examine how the protein could be used to help treat heart conditions.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.